EUVIMEDEUVIMED entdecken
Open Access

Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning

Alan K Davis, Joseph P Barsuglia, Austin-Marley Windham-Herman, Marta Lynch, Martin Polanco

Journal of Psychedelic Studies · 2017-11 · 1 (2) · 65-73

DOI: 10.1556/2054.01.2017.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Psychedelic Studies, 2017-11. Verfasst von Alan K Davis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins School of Medicine, Baltimore, MD, USA. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: Very few studies have reported the effectiveness of ibogaine as a treatment for chronic opioid use. Therefore, this study evaluated the acute subjective effects of ibogaine, outcomes on problematic opioid consumption, and the long-term associations with psychological functioning. METHODS: Using online data collection, 88 patients who received ibogaine treatment in Mexico between 2012 and 2015 completed our survey. RESULTS: Most participants (72%) had used opioids for at least 4 years and 69% reported daily use. Most (80%) indicated that ibogaine eliminated or drastically reduced withdrawal symptoms. Fifty percent reported that ibogaine reduced opioid craving, some (25%) reporting a reduction in craving lasting at least 3 months. Thirty percent of participants reported never using opioids again following ibogaine treatment. And over one half (54%) of these abstainers had been abstinent for at least 1 year, with 31% abstinent for at least 2 years. At the time of survey, 41% of all participants reported sustained abstinence (>6 months). Although 70% of the total sample reported a relapse following treatment, 48% reported decreased use from pretreatment levels and an additional 11% eventually achieved abstinence. Treatment responders had the lowest rates of depressive and anxious symptoms, the highest levels of subjective well-being and rated their ibogaine treatment as more spiritually meaningful compared with treatment non-responders. CONCLUSION: The results suggest that ibogaine is associated with reductions in opioid use, including complete abstinence, and has long-term positive psychological outcomes. Future research should investigate the efficacy of ibogaine treatment using rigorous longitudinal and controlled designs.

Schlagwörter

Stichwörter der Autor:innen

effectivenessheroinibogaineoutcomesprescription opioids

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Crossroads Treatment Center, Rosarito, Mexico.
  • Yale School of Medicine, New Haven, CT, USA.

Förderung

  • NIAAA NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Davis, A. K., Barsuglia, J. P., Windham-Herman, A. M., Lynch, M., & Polanco, M. (2017). Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning. Journal of Psychedelic Studies, 1(2), 65-73. https://doi.org/10.1556/2054.01.2017.009

Vancouver

Davis AK, Barsuglia JP, Windham-Herman AM, Lynch M, Polanco M. Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning. Journal of Psychedelic Studies. 2017;1(2):65-73. doi:10.1556/2054.01.2017.009

BibTeX
@article{Davis2017,
  author = {Davis, Alan K and Barsuglia, Joseph P and Windham-Herman, Austin-Marley and Lynch, Marta and Polanco, Martin},
  title = {Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning},
  journal = {Journal of Psychedelic Studies},
  year = {2017},
  volume = {1},
  number = {2},
  pages = {65--73},
  doi = {10.1556/2054.01.2017.009}
}
Kostenlos starten →